The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization
- PMID: 39315294
- PMCID: PMC11417043
- DOI: 10.3389/fnmol.2024.1400118
The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization
Abstract
The transient receptor potential vanilloid 1 (TRPV1) channel plays a dual role in peripheral neuropathic pain (NeuP) by acting as a "pain switch" through its sensitization and desensitization. Hyperalgesia, commonly resulting from tissue injury or inflammation, involves the sensitization of TRPV1 channels, which modulates sensory transmission from primary afferent nociceptors to spinal dorsal horn neurons. In chemotherapy-induced peripheral neuropathy (CIPN), TRPV1 is implicated in neuropathic pain mechanisms due to its interaction with ion channels, neurotransmitter signaling, and oxidative stress. Sensitization of TRPV1 in dorsal root ganglion neurons contributes to CIPN development, and inhibition of TRPV1 channels can reduce chemotherapy-induced mechanical hypersensitivity. In diabetic peripheral neuropathy (DPN), TRPV1 is involved in pain modulation through pathways including reactive oxygen species and cytokine production. TRPV1's interaction with TRPA1 channels further influences chronic pain onset and progression. Therapeutically, capsaicin, a TRPV1 agonist, can induce analgesia through receptor desensitization, while TRPV1 antagonists and siRNA targeting TRPV1 show promise in preclinical studies. Cannabinoid modulation of TRPV1 provides another potential pathway for alleviating neuropathic pain. This review summarizes recent preclinical research on TRPV1 in association with peripheral NeuP.
Keywords: TRPV1; desensitization; molecular mechanisms; peripheral neuropathic pain; sensitization.
Copyright © 2024 Gao, Li, Wang, Liu and Guo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Abrams R. M. C., Pedowitz E. J., Simpson D. M. (2021). A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults. Expert. Rev. Neurother. 21, 259–266. doi: 10.1080/14737175.2021.1874920, PMID: - DOI - PubMed
-
- Agarwal N., Taberner F. J., Rangel Rojas D., Moroni M., Omberbasic D., Njoo C., et al. . (2020). SUMOylation of enzymes and ion channels in sensory neurons protects against metabolic dysfunction, neuropathy, and sensory loss in diabetes. Neuron 107, 1141–1159.e7. doi: 10.1016/j.neuron.2020.06.037, PMID: - DOI - PubMed
-
- Akopian A. N., Ruparel N. B., Jeske N. A., Hargreaves K. M. (2007). Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J. Physiol. 583, 175–193. doi: 10.1113/jphysiol.2007.133231, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
